1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ALX Oncology Holdings Inc (ALXO)

  7. ALX Oncology Holdings Inc (ALXO) Financials

ALXO

ALX Oncology Holdings Inc
4.67
-0.20 (-4.11%)
Upgrade to Real-Time

ALX Oncology Holdings Inc. (ALXO) Fundamentals
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
SHARE INFORMATION
Market CapUS$ 196,142,635
Shares Outstanding40,863,049
Float21,456,220
Percent Float52.51%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -3.03
Latest Fiscal Date2022-12-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions312
Institutional Holdings Date2023-02-28
Institutional Bought Previous 3 Months2,008,929
Institutional Holdings Percent124.9%
Institutional Sold Previous 3 Months5,603,523
Insider Holdings Date2023-02-28
Insider Bought Previous 3 Months46,474
Insider Holdings Percent2.5
Insider Sold Previous 3 Months52,698
Insider Shares Owned1,039,039
TRADING INFO
52 Week HighUS$ 19.85
52 Week LowUS$ 4.52
52 Week High ChangeUS$ -74.58
21 Day Moving AverageUS$ 5.9019
21 Day Extended Moving AverageUS$ 5.8825
50 Day Moving AverageUS$ 7.6038
50 Day Extended Moving AverageUS$ 7.3074
200 Day Moving AverageUS$ 10.1038
200 Day Extended Moving AverageUS$ 12.0367
10 Day Average Volume429,939
20 Day Average Volume295,524
30 Day Average Volume247,444
50 Day Average Volume220,192
Alpha-0.032652
Beta1.7565
Standard Deviation0.266729
R20.130730
7 Day Price ChangeUS$ -0.39
7 Day Percent Change-7.51%
21 Day Price ChangeUS$ -1.73
21 Day Percent Change-26.49%
30 Day Price ChangeUS$ -2.35
30 Day Percent Change-32.87%
Month to Date Price ChangeUS$ -1.82
Month to Date Percent Change-27.49%
Quarter to Date Price ChangeUS$ -6.47
Quarter to Date Percent Change-57.41%
180 Day Price ChangeUS$ -5.78
180 Day Percent Change-54.63%
200 Day Price ChangeUS$ -8.54
200 Day Percent Change-64.02%
Year to Date Price ChangeUS$ -6.47
Year to Date Percent Change-57.41%

ALX Oncology Holdings Inc. (ALXO) Key Ratios

PROFITABILITY
EBIT Margin-10,177.4%
EBITDA Margin-10,159.6%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin9.1%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.80
Total Debt To Equity0.00
Int Coverage-40,409.70
Current Ratio9.60
Leverage Ratio1.10
Quick Ratio9.40
Long Term Debt To Capital0.03
VALUATION MEASURES
PE Ratio-2.20
Enterprise ValueUS$ -59,225,735
Price to Sales0.00
Price to Free Cash-2.20
PE High Last 5 Years0.00
Price To Book0.80
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.80
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-35.97
Return on Equity-39.42
Return on Capital-35.39

ALX Oncology Holdings Inc. (ALXO) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorKPMG LLP
CEOJaume Pons
Emplyoees58
Last AuditUE
CIK0001810182
IndustryBiotechnology
SectorHealthcare
NAICSResearch and Development in Biotechnology (except Nanobiotechnology)(541714)
CONTACT INFO
Address323 Allerton Avenue
Suite 100
South San Francisco, CA 94080
Websitehttps://www.alxoncology.com
Facsimile-
Telephone+1 650 466-7125
Email-
Your Recent History
NASDAQ
ALXO
ALX Oncolo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20230325 19:39:10